2006, Number 2
<< Back Next >>
Bol Med Hosp Infant Mex 2006; 63 (2)
Common difficulties in the integral management of children with ADHD in Mexico.
Garza-Morales S, Barragán-Pérez E
Language: Spanish
References: 27
Page: 145-154
PDF size: 100.56 Kb.
ABSTRACT
Problems in the scholastic achievement, low academic performance and behavioral disturbances of children are very common in the daily clinical practice of pediatricians in Mexico. Difficulties are related to options regarding pharmacologic as well as educational interventions. We describe the diagnostic tools for this kind of problems; and an integral point of view of the different therapeutic options, the strengths and weaknesses of diverse educational approaches and the pharmacological therapy. Finally,
recommendations are presented for the management of these children and their families in the pediatrician office.
REFERENCES
Barragán E. El niño y el adolescente con trastorno por déficit de atención, su mundo y sus soluciones. 2da. ed. México: Linae Editores; 2003.
Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry. 1998; 59 Suppl 7: 4-16.
Goldman LS, Genel M, Bezmqan RJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 1998; 279: 1100-6.
Cantwell D. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1996; 35: 978-9.
Barragán E, Garza S, Galindo G, Ricardo J. Attention deficit disorder and low birth weight in term children: Their association and the neuropsychological implications. J Neurol Sci. 2001; 187 Suppl 1: S359-60.
Barragán E. Daño neurológico y epilepsia. Estrategia y herramientas multidisciplinarias de apoyo. México: Linae Editores; 2004.
Keith C. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry. 2001; 40: 2-6.
Schweitzer JB, Cummins TK, Kant CA. Attention-deficit/hyperactivity disorder. Med Clin North Am. 2001; 85: 757-77.
Touzin M. Academic difficulties in hyperactive children. Rev Pract. 2002; 52: 1998-2001.
Barkley RA. Psychosocial treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002; 63 Suppl 12: 36-43.
Harwood TM, Beutler LE. What does the MTA study tell us about effective psychosocial treatment for ADHD? J Clin Child Psychol. 2001; 30: 141-3.
Stevens S. The LD child and ADHD child. USA: Winston-Salem; 1997.
Cupello S. Cognitive aspects of attention deficit hyperactivity disorder in children. Rev Pract. 2002; 52: 2005-8.
Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliot G. National Institute of Mental Health. Collaborative multimodal treatment study of children with ADHD (The MTA). Arch Gen Psychiatry. 1997; 54: 863-70.
Kirby K, Rutman LE, Bernstein H. Attention-deficit/hyperactivity disorder: a therapeutic update. Curr Opin Pediatr. 2002; 14: 236-46.
Ruiz-García M, Garza-Morales S, Sánchez-Guerrero O, Loredo-Abdalá A. Conclusiones del consenso de expertos sobre el tratamiento farmacológico del trastorno por déficit de atención con o sin hiperactividad. Bol Med Hosp Infant Mex. 2003; 60: 349-55.
Ghuman JK, Ginsburg GS. Psychostimulants in preschool children with ADHD: clinical evidence from a developmental disorder. J Am Acad Child Adolesc Psychiatry. 2001; 40: 516-24.
Wender EH. Managing stimulant medication for attention-deficit/hyperactivity disorder: an update. Pediatr Rev. 2002; 23: 234-6.
Greenhill LL, Pliszka S, Dulcan MK. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002; 41: S26-49.
Weber P, Lutschg J. Methylphenidate treatment. Pediatr Neurol. 2002; 26: 261-6.
Pelham WE, Gnagy EM, Burrows L. Once-a-day concerta metylphenidate versus three times daily methylphenidate. Pediatrics. 2001; 107: 105.
Popper CW. Antidepressants in the treatment of ADHD. J Clin Psychiatry. 1997;58:14-29.
Fletcher. Efficacy of modafinil compared to dextroamphetamines for the treatment of ADHD in adults. J Child Adolesc Psychopharmacol. 2000; 10: 311-20.
Spencer TJ, Biederman J, Wilens TE, Faraone SV. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002; 63: 16-22.
Schweitzer JB, Holcomb HH. Drugs under investigation for attention-deficit hyperactivity disorder. Curr Opin Invest Drugs. 2002; 3: 1207-11.
Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry. 2002; 63: s50-5.
George G. Psychotherapy in children with attention deficit hyperactivity disorder. Rev Pract. 2002; 52: 2013-6.